Home » Topics » BioWorld Science

BioWorld Science
RSS

Boehringer Ingelheim identifies new Bruton tyrosine kinase inhibitors

May 3, 2019

Merck & Co. presents indoleamine 2,3-dioxygenase 1 inhibitors

May 3, 2019

Shanghai De Novo Pharmatech patents adenosine A2A receptor antagonists

May 3, 2019

Qternmet XR approved in U.S. for type 2 diabetes

May 3, 2019

FDA approves Tibsovo for newly diagnosed IDH1 mutant AML ineligible for intensive chemotherapy

May 3, 2019

FDA issues second complete response letter for Barhemsys

May 3, 2019

Phase III study of Trelegy Ellipta in uncontrolled asthma meets primary endpoint

May 3, 2019

Novel LFA-1 antagonist VVN-001 for treating dry eye disease

May 3, 2019

Samumed launches phase III clinical program for lorecivivint in knee osteoarthritis

May 3, 2019

Galectin-4 as a novel biomarker in infants with intestinal disease

May 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...